Literature DB >> 31241327

Morphology Tailoring of ZnWO4 Crystallites/Architectures and Photoluminescence of the Doped RE3+ Ions (RE = Sm, Eu, Tb, and Dy).

Meiting Li, Toshiaki Takei, Qi Zhu, Byung-Nam Kim, Ji-Guang Li.   

Abstract

Tartrate (Tar2-) was originally employed in this work as a chelating/structure-directing agent for hydrothermal crystallization of ZnWO4, where the decisive roles of Tar2-/Zn2+/WO42- molar ratio, solution pH (7-10), and the use of ethylene glycol (EG) cosolvent in phase/morphology evolution were deciphered in detail. It was unambiguously manifested that Tar2- may remarkably retard the intrinsically preferred [001] growth of ZnWO4, transform 1D nanorods to 0D nanoparticles and then to 2D platelets, and meanwhile induce face-to-face alignment of the platelets to form spheroidal, ellipsoidal and snowflakelike 3D architectures, where the 2D crystallites were revealed to develop via oriented attachment (colattice) of non-(00l) facets. A lower solution pH and excessive WO42- were clearly shown to enhance and offset the effect of Tar2-, which led to ellipsoidal assemblies of substantially larger 2D crystallites and suppressed 2D growth/3D assembly of ZnWO4 crystallites, respectively. With the spheroidal architectures for example, doping ZnWO4 with RE3+ yielded (Zn0.98RE0.02)WO4 phosphors (RE = Sm, Eu, Tb, and Dy, respectively) that show luminescence overlapped from the typical linelike and broad-band (∼350-700 nm) emissions of RE3+ and WO6, respectively. The luminescence color of the sample was found to drift away from the blue corner of the CIE chromaticity diagram with RE3+ doping and to be dependent on the type of RE3+.

Entities:  

Year:  2019        PMID: 31241327     DOI: 10.1021/acs.inorgchem.9b01271

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Effect of Li+ doping on the luminescence performance of a novel KAlSiO4:Tb3+ green-emitting phosphor.

Authors:  Reziwanguli Yantake; Muyasier Kaiheriman; Taximaiti Yusufu; Aierken Sidike
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.